The transition team for the Food and Drug Administration in the Trump administration is starting to take shape, with key players being identified for important roles. Lowell Zeta, a former senior counselor to ex-Commissioner Stephen Hahn, is playing a pivotal role in outreach and recruiting efforts for the FDA transition. Zeta, who is currently a partner at the law firm Hogan Lovells, brings a wealth of experience from his time at the FDA, where he spearheaded the agency’s response to the Covid-19 pandemic in 2020.
Zeta’s involvement in evaluating the FDA’s Covid-19 response and preparing for future pandemics showcases his expertise in regulatory practices and crisis management. His experience at the highest levels of the FDA makes him a valuable asset to the transition team as they navigate the complex landscape of public health and regulatory policies.
In addition to Zeta, the transition team is also in discussions with a top Capitol Hill aide about a key role at the agency. This collaboration highlights the importance of building relationships with key stakeholders in government to ensure a smooth transition and effective governance.
The team’s efforts are crucial as they work to ensure continuity and efficiency in the FDA’s operations during this period of transition. With the appointment of key personnel like Zeta and the engagement of Capitol Hill aides, the Trump administration is laying the groundwork for a successful FDA transition that prioritizes public health and safety.
For more in-depth analysis and exclusive content, subscribe to STAT+ for access to premium articles, newsletters, events, and news alerts. Unlock the full potential of our platform and stay informed about the latest developments in the healthcare industry.
